Brian Elenbaas

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Smoking Cessation

Small Cell Lung Cancer

Oxidative Stress

Neuroendocrine Tumors

Top Venues

EMBO molecular medicine

NPJ precision oncology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher W Schultz, Yang Zhang, Rajaa El Meskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, Suresh Kumar, Nobuyuki Takahashi, Devon A Atkinson, Liton Kumar Saha, Chien-Fei Lee, Brian Elenbaas, Parth Desai, Robin Sebastian, Ajit Kumar Sharma, Melissa Abel, Brett A Schroeder, Manan Krishnamurthy, Laurel L Bassel, Rajesh Kumar, Nitin Roper, Mirit I Aladjem, Frank T Zenke, Zoe Weaver Ohler, Yves Pommier, Anish Thomas
Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer. EMBO molecular medicine (2024)
Danyi Wang, Brian Elenbaas, Karthikeyan Murugesan, Kunal Shah, Meagan Montesion, Ioannis Gounaris, Juergen Scheuenpflug, Giuseppe Locatelli, Zheng Feng
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays. NPJ precision oncology 7 (1) (2023)
Audrey Turchick, Astrid Zimmermann, Li-Ya Chiu, Heike Dahmen, Brian Elenbaas, Frank T Zenke, Andree Blaukat, Lyubomir T Vassilev
Selective inhibition of ATM-dependent double-strand break repair and checkpoint control synergistically enhances the efficacy of ATR inhibitors. Molecular cancer therapeutics (2023)
Christopher W Schultz, Yang Zhang, Rajaa El Meskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, Suresh Kumar, Nobuyuki Takahashi, Devon A Atkinson, Liton Kumar Saha, Chien-Fei Lee, Brian Elenbaas, Parth Desai, Robin Sebastian, Ajit Kumar Sharma, Melissa Abel, Brett A Schroeder, Manan Krishnamurthy, Rajesh Kumar, Nitin Roper, Mirit I Aladjem, Frank T Zenke, Zoe Weaver Ohler, Yves Pommier, Anish Thomas
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer. EMBO molecular medicine (2023)